NASDAQ : XCUR

Exicure, Inc. — Company profile

Healthcare · Biotechnology · United States

Last price 0.9348 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 6.12M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.

Details

NameExicure, Inc.
SectorHealthcare
IndustryBiotechnology
Employees1
Founded2011
CeoJungsoo Kim
CountryUnited States
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
IsinUS30205M3097
Cusip30205M309
Cik1698530
Sic2834
Stock TypeCommon Stock

Key executives

NameTitle
Jungsoo KimChief Executive Officer, President and Director
Gyuyeob LeeInterim Chief Financial Officer and Secretary
Young Seung KoChief Operating Officer
Joshua MillerChief Accounting Officer
Dr. Devki Sukhtankar Ph.D.Head of Preclinical Research and Translational Medicine
Dr. Niña Caculitan Ph.D.Head of Clinical

Contact

Address400 Seaport Court, Suite 102, Redwood City, California 94063, United States
Phone847 673 1700
Websitehttps://www.exicuretx.com